Xermelo Tablet
NDC 70183-125
Product Information
Xermelo (telotristat ethyl) is a NDA-approved product labeled by Lexicon Pharmaceuticals, Inc.. This medication is typically used as a tryptophan hydroxylase inhibitor [epc]. It is supplied as a white tablet for oral administration. This product entry covers the primary NDC 70183-125 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
- Oral - Administration to or by way of the mouth.
- Oral - Administration to or by way of the mouth.
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
T;E;250 Code Structure Chart
Product Details
What is NDC 70183-125?
What are the uses of this product?
What are Active Ingredients of this product?
- TELOTRISTAT ETHYL 250 mg/1 - used for treatment of carcinoid syndrome
- TELOTRISTAT ETHYL 250 mg/1 - used for treatment of carcinoid syndrome
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TELOTRISTAT ETHYL (UNII: 8G388563M7)
- TELOTRISTAT (UNII: 381V4FCV2Z) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)
- HYDROXYPROPYL CELLULOSE (90000 WAMW) (UNII: UKE75GEA7F)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
- TALC (UNII: 7SEV7J4R1U)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1872453 - telotristat ethyl 250 MG Oral Tablet
- RxCUI: 1872453 - telotristat ethyl 250 MG (as telotristat etiprate 328 MG) Oral Tablet
- RxCUI: 1872458 - XERMELO 250 MG Oral Tablet
- RxCUI: 1872458 - telotristat ethyl 250 MG Oral Tablet [Xermelo]
- RxCUI: 1872458 - Xermelo 250 MG (as telotristat etiprate 328 MG) Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.
Patient Education
Telotristat
Telotristat is used in combination with another medication (a somatostatin analog [SSA] such as lanreotide, octreotide, pasinreotide) to control diarrhea caused by carcinoid tumors (slow-growing tumors that release natural substances that can cause symptoms like diarrhea) in patients with diarrhea not controlled by a somatostatin analog alone. Telotristat is in a class of medications called antidiarrheal agents. It works by blocking the formation of a certain natural substance in the body that is released by the carcinoid tumors and causes diarrhea.
[Learn More]
* Please review the full disclaimer at the bottom of this page.